Nevertheless, in other studies [15,16,17,18,19], the AMH levels of gynecologic patients of reproductive age prior to receiving cancer treatment were compared to those of non-gynecological cancer patients, and no significant difference was found. This evidence concerns the gene AMH and female reproductive organ cancer.